Zymeworks
ZYME
46 hedge funds and large institutions have $130M invested in Zymeworks in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 10 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 9
30% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 10
8% more capital invested
Capital invested by funds: $121M → $130M (+$9.58M)
7% more funds holding
Funds holding: 43 → 46 (+3)
5.36% less ownership
Funds ownership: 31.47% → 26.11% (-5.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$8.3M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$3.46M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$1.76M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.2M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$6.65M |
| 2 |
MWNA
Marshall Wace North America
New York
|
-$3.39M |
| 3 |
JGC
J. Goldman & Co
New York
|
-$1.5M |
| 4 |
LCM
Laurion Capital Management
New York
|
-$1.39M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$893K |
ZYME Hedge Fund Activity: Q3 2018 in Review
46 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q3 2018, worth a combined $130M — up 7.9% from $121M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new ZYME positions and 10 closed out — a net gain of 3 holders — while 15 added to existing stakes and 9 trimmed.
The largest buyer was Farallon Capital Management, adding an estimated $8.3M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $6.65M sold.
- 46 institutional investors held Zymeworks (ZYME) as of Q3 2018, up from 43 in Q2 2018.
- Funds reported $130M of Zymeworks stock for Q3 2018, up 7.9% quarter-over-quarter.
- 13 funds opened new Zymeworks positions in Q3 2018 and 10 closed out, a net change of +3 holders.
- The largest Zymeworks buyer in Q3 2018 was Farallon Capital Management, an estimated $8.3M added.
- The largest Zymeworks seller in Q3 2018 was Alyeska Investment Group, an estimated $6.65M sold.
Based on aggregated 13F filings for Q3 2018.